Skip to main content
. 2017 Dec 22;33(1):271–285. doi: 10.1080/14756366.2017.1414807

Figure 1.

Figure 1.

Roscivitine and purine isosteres as small-molecule inhibitors of CDK under clinical evaluations for the treatment of cancer.